Delivery Order SPE2DB24D1104-SPE2DB25FYFE2
Award Date 9/2/25
Potential Completion Date 9/3/25
Potential Value $16K
Federal Agency
Awardee
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Competed under SAP
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Simplified Acquisition
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Defense Logistics Agency awarded a delivery order valued at $11,801.43 to AmerisourceBergen Drug Corp for the supply of Contrave ER 8-90 mg tablets (120 count) on August 5, 2025, with completion scheduled for August 6, 2025. This firm fixed-price delivery order was competitively awarded with no set-aside designation and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. Contrave is an FDA-approved prescription medication used for chronic weight...
- The Defense Logistics Agency awarded a delivery order valued at $2,831.99 to AmerisourceBergen Drug Corp for the supply of Contrave ER 8-90 mg tablets (120 count) on August 22, 2025, with completion scheduled for August 25, 2025. This competitively awarded, firm fixed-price delivery order carries no set-aside designation and will be performed at the contractor's facility in Conshohocken, Pennsylvania. Contrave is a prescription medication used for weight management, reflecting the Defense...
- The U.S. Defense Logistics Agency (DLA) awarded a $2,028.78 firm fixed price delivery order contract to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation, to supply 4564244773 CONTRAVE ER 8-90 MG TABLET 120S. This delivery order falls under a larger indefinite delivery contract (IDC) awarded by DLA to AmerisourceBergen Drug Corp, valued at up to $999,999,999.00 through December 31, 2025. The IDC serves as the primary contract vehicle for AmerisourceBergen to deliver...
- The Defense Logistics Agency awarded a delivery order valued at $8,623.35 to AmerisourceBergen Drug Corp for the supply of Contrave ER 8-90 mg tablets (120-count units) on August 14, 2025, with an ultimate completion date of August 15, 2025. This firm fixed price delivery order represents a competitive award with no set-aside designation and will be performed at the vendor's corporate office location in Conshohocken, Pennsylvania. Contrave is an FDA-approved weight management medication...
- The U.S. Defense Logistics Agency (DLA) Troop Support Medical awarded a firm fixed price delivery order contract to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation, for the provision of 4,564,110,296 units of the prescription medication CONTRAVE ER 8-90 MG TABLET 120S. The $38,493.65 contract has a performance period through March 29, 2024 and does not have a set-aside designation. This delivery order is issued under a larger $999,999,999.00 indefinite delivery...
- The U.S. Defense Logistics Agency (DLA) awarded a $5,563.06 firm fixed price delivery order contract to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation, to provide 120 tablets of the medication CONTRAVE ER 8-90 MG. This delivery order is part of a larger indefinite delivery contract (IDC) awarded solely to AmerisourceBergen Drug Corp, with a potential value of $999,999,999.00 and a performance period through December 31, 2025. The IDC serves as the primary contract...
- The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation, to provide 4,564,186,212 CONTRAVE ER 8-90 MG TABLET 120S. The $1,359.47 contract has an ultimate completion date of April 8, 2024 and does not have a set-aside designation. This delivery order is issued under an existing indefinite delivery contract (IDC) awarded solely to AmerisourceBergen Drug Corp, with a potential value of...
- The U.S. Defense Logistics Agency Troop Support Medical has awarded a firm fixed price delivery order contract worth $2,567.10 to AmerisourceBergen Drug Corp, a subsidiary of the global pharmaceutical distributor AmerisourceBergen Corporation. The contract is for the provision of CONTRAVE ER 8-90 MG TABLET 120S, a prescription medication, with a period of performance through January 29, 2024. This order is issued under an existing indefinite delivery contract (IDC) held by AmerisourceBergen Drug...
- This $5,203.48 firm fixed-price delivery order was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA) Troop Support Medical. The contract is for the supply of CONTRAVE ER 8-90 MG TABLET 120S, a medication used in the treatment of obesity and related health conditions. This delivery order is part of a larger Indefinite Delivery Contract (IDC) worth up to $999,999,999 that Amerisourcebergen holds with the DLA Troop Support Medical,...
- This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $3,338.29, is for the delivery of CONTRAVE ER 8-90 MG TABLET 120S, a medication used in the treatment of obesity. The contract has an ultimate completion date of December 13, 2024. This delivery order is part of a larger Indefinite Delivery Contract (IDC) that AmerisourceBergen holds...